NEW YORK (GenomeWeb News) – Genalyte today announced it has inked distribution deals for its Maverick Detection System covering parts of Europe.

The system, which analyzes multiple antibodies and other proteins, also received the CE Mark for research use in Europe.

San Diego-based Genalyte has reached distribution deals with Mokascience in France; Bucher Biotec in Switzerland; and KRD Molecular Technologies in the Czech Republic, Slovakia, and Hungary. The deals are the firm's first in Europe, it noted.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.